Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Depreciation & Amortization (IS) (2016 - 2025)

BioCorRx's Depreciation & Amortization (IS) history spans 15 years, with the latest figure at $71986.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (IS) rose 972.18% year-over-year to $71986.0; the TTM value through Sep 2025 reached $181810.0, up 576.98%, while the annual FY2024 figure was $33145.0, 23.64% up from the prior year.
  • Depreciation & Amortization (IS) for Q3 2025 was $71986.0 at BioCorRx, roughly flat from $71977.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $71986.0 in Q3 2025 and bottomed at $6665.0 in Q1 2023.
  • The 5-year median for Depreciation & Amortization (IS) is $6863.0 (2021), against an average of $16870.4.
  • The largest annual shift saw Depreciation & Amortization (IS) plummeted 65.25% in 2021 before it soared 972.18% in 2025.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $6863.0 in 2021, then decreased by 0.01% to $6862.0 in 2022, then dropped by 2.14% to $6715.0 in 2023, then soared by 93.66% to $13004.0 in 2024, then skyrocketed by 453.57% to $71986.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Depreciation & Amortization (IS) are $71986.0 (Q3 2025), $71977.0 (Q2 2025), and $24843.0 (Q1 2025).